441 results on '"Sangiovanni, Angelo"'
Search Results
2. Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy
3. Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care
4. Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy
5. Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
6. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
7. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
8. SAT-493-YI ASAP score may predict HCC recurrence after complete radiological response to locoregional treatments
9. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
10. SAT-481-YI Improved handling of BCLC 2022 update in the management of hepatocellular carcinoma in clinical practice
11. SAT-482 A modified Charlson comorbidity index to improve management of patients with hepatocellular carcinoma: a step towards precision medicine
12. OS-061 Chronic hepatitis C virus infection induces HCC risk by perturbing the human liver circadian transcriptome and epigenome through deregulation of the deacetylase SIRT1
13. Chemotherapy-induced bowel ischemia: diagnostic imaging overview
14. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma
15. Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy.
16. Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.
17. Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
18. Incidence of liver and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
19. Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.
20. Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) Guidance
21. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
22. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance
23. Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
24. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
25. Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
26. Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak
27. Radiotherapy and Chemotherapy Features in the Treatment for Locoregional Recurrence of Endometrial Cancer: A Systematic Review
28. Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
29. Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
30. Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation
31. A 3-year course of bulevirtide monotherapy may cure HDV infection in patients with cirrhosis
32. Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk Assessment
33. A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene
34. Contributors
35. Premalignant and Early Malignant Hepatocellular Lesions in Chronic Hepatitis/Cirrhosis
36. Benign Liver Tumors
37. Contributors
38. Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients
39. Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatment in US or US Fusion-Guided Microwave Ablation of Liver Tumors
40. Non-Oncological Radiotherapy: A Review of Modern Approaches
41. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma
42. Usefulness of longitudinal assessment of AFP in DAA cured HCV cirrhotic patients to predict the developmente of HCC
43. Advanced precancerous lesions in the liver
44. Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis
45. Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma
46. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma
47. Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
48. Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
49. A Trimodality, Four-Step Treatment including Chemotherapy, Pleurectomy/Decortication and Radiotherapy in Early-Stage Malignant Pleural Mesothelioma: A Single-Institution Retrospective Case Series Study
50. An Unprecedented Challenge: The North Italian Gastroenterologist Response to COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.